Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Poznansky, Ph.D., M.B.,Ch.B.

Co-Author

This page shows the publications co-authored by Mark Poznansky and Chongzhao Ran.
Connection Strength

0.440
  1. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB J. 2019 05; 33(5):6596-6608.
    View in: PubMed
    Score: 0.201
  2. AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression. Cancer Immunol Res. 2018 05; 6(5):539-551.
    View in: PubMed
    Score: 0.188
  3. CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer. Oncotarget. 2019 Jul 09; 10(43):4479-4491.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.